Startups
Skyviews Life Science is a privately held advisory company specialised in personalised health.
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 6, 2022 | BREAKING: Crop gene editor Tropic Biosciences banks $35m in fresh funding | UK ag gene-editing startup Tropic Biosciences has raised $35 million for its latest funding round, it announced today. Swiss impact investor Blue Horizon led the bridge round. ADQ, Bloom8 (previously Rage Capital), Skyviews Life Science, Su... |
| Mar 16, 2021 | Swiss cellular meat startup Mirai Foods raises $4.5m with second seed close | Mirai Foods — which claims to be Switzerland’s “first and to date only cultivated meat startup” — has raised $2.2 million in a second close of its seed round. The second tranche followed an earlier seed capital injection that closed in Janu... |
| Mar 15, 2021 | Lab grown meat company MIRAI FOODS increases seed financing to USD 4.5 million | |
| Mar 15, 2021 | Lab grown meat company MIRAI FOODS increases seed financing to USD 4.5 million | The new backers of the company include German Family Office FRIBA Investment, Swiss Advanced Nutrition & Biotech VC Skyviews Life Science as well as Zürich based serial entrepreneur and tech investor Ulf Claesson. |
| Jan 27, 2021 | Anti-allergy startup Ukko scores $40m in Bayer-led Series B | Israeli biotech startup Ukko has raised $40 million in a Series B round led by Bayer‘s corporate venture unit, Leaps by Bayer. Joining the funding were US agrifood conglomerate Continental Grain Company, Malta-based PeakBridge Ventures, Swi... |
| Jan 27, 2021 | BREAKING: Anti-allergy startup Ukko scores $40m in Bayer-led Series B | Israeli biotech startup Ukko has raised $40 million in a Series B round led by Bayer‘s corporate venture unit, Leaps by Bayer. Joining the funding were US agrifood conglomerate Continental Grain Company, Malta-based PeakBridge Ventures, Swi... |
| Dec 2, 2020 | French startup lands $8.7M to advance microbiome therapies | Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D Yu... |
| Jun 3, 2020 | Tropic Biosciences banks $28.5m in Temasek-led Series B for gene-editing, RNAi approach | Losing a crop to a pest or disease is a devastating outcome for a farmer. If that farmer is based in a developing country without the promise of subsidies or crop insurance, it’s even direr. And in a pandemic world where food supply chains ... |
| French startup lands $8.7M to advance microbiome therapies | A French startup has raised $8.7 million that it will use to advance large-scale production of therapies based on the human microbiome, a teeming world of bacteria seen as a key to better health. Founded in 2014, Lyon, France-based MaaT Pha... |
Reviews 0
FAQ about Skyviews Life Science
What has the press written about Skyviews Life Science?
Parsers VC has collected 10 articles mentioning Skyviews Life Science, among them “BREAKING: Crop gene editor Tropic Biosciences banks $35m in fresh funding” (Jul 6, 2022) and “Swiss cellular meat startup Mirai Foods raises $4.5m with second seed close” (Mar 16, 2021).
Is Skyviews Life Science still active?
Yes, Skyviews Life Science is active; its latest activity on Parsers VC dates from Dec 12, 2024.